These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical crossroads: a 21-year-old woman with menstrual irregularity. Littell JT JAMA; 1997 Sep; 278(10):822. PubMed ID: 9293989 [No Abstract] [Full Text] [Related]
3. Supplementation with vitamin C and/or vitamin B(6) in the prevention of Depo-Provera side effects in adolescents. Harel Z; Biro F; Kollar L; Riggs S; Flanagan P; Vaz R J Pediatr Adolesc Gynecol; 2002 Jun; 15(3):153-8. PubMed ID: 12106752 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and acceptability of depo-medroxyprogesterone acetate injection. As a method of contraception in Saudi Arabia. Sobande AA; Al-Bar HM; Archibong EI; Sadek AA Saudi Med J; 2000 Apr; 21(4):348-51. PubMed ID: 11533816 [TBL] [Abstract][Full Text] [Related]
5. Bleeding problems and progestogen-only contraception. Porter C; Rees MC J Fam Plann Reprod Health Care; 2002 Oct; 28(4):178-81. PubMed ID: 12419054 [No Abstract] [Full Text] [Related]
6. Menstrual pattern and lipid profiles during use of medroxyprogesterone acetate and estradiol cypionate and NET-EN (200 mg) as contraceptive injections. Canto de Cetina TE; Luna MO; Cetina Canto JA; Bassol S Contraception; 2004 Feb; 69(2):115-9. PubMed ID: 14759615 [TBL] [Abstract][Full Text] [Related]
8. WHO statement on hormonal contraception and bone health. d'Arcangues C Contraception; 2006 May; 73(5):443-4. PubMed ID: 16627029 [No Abstract] [Full Text] [Related]
9. Dealing with Depo: you can manage bleeding with estrogen, ibuprofen. Contracept Technol Update; 1995 Dec; 16(12):145-8. PubMed ID: 12347032 [TBL] [Abstract][Full Text] [Related]
10. Medroxyprogesterone acetate (Depo-Provera) and bone mineral density loss. Wooltorton E CMAJ; 2005 Mar; 172(6):746. PubMed ID: 15743913 [No Abstract] [Full Text] [Related]
15. Effect of Depo-Provera on the vaginal epithelium and cervical ectopy: report on a study in progress. Mauck C AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S131. PubMed ID: 9581897 [No Abstract] [Full Text] [Related]
16. Depo-Provera and skeletal health: reviewing the evidence; developing and disseminating a consensus. Guilbert ER; Kaunitz AM Contraception; 2009 Mar; 79(3):165-6. PubMed ID: 19185667 [No Abstract] [Full Text] [Related]
17. Counseling for Depo a must. Family Plan World; 1993; ():8. PubMed ID: 12290813 [TBL] [Abstract][Full Text] [Related]
18. Progestogen-only contraceptives and cancer risk. La Vecchia C; Franceschi S Eur J Cancer Prev; 2002 Apr; 11(2):113-5. PubMed ID: 11984127 [No Abstract] [Full Text] [Related]